159 related articles for article (PubMed ID: 21757745)
1. Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability.
Sánchez FA; Rana R; González FG; Iwahashi T; Durán RG; Fulton DJ; Beuve AV; Kim DD; Durán WN
J Biol Chem; 2011 Sep; 286(35):30409-30414. PubMed ID: 21757745
[TBL] [Abstract][Full Text] [Related]
2. Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules.
Sánchez FA; Kim DD; Durán RG; Meininger CJ; Durán WN
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1642-8. PubMed ID: 18708444
[TBL] [Abstract][Full Text] [Related]
3. Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability.
Sánchez FA; Rana R; Kim DD; Iwahashi T; Zheng R; Lal BK; Gordon DM; Meininger CJ; Durán WN
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6849-53. PubMed ID: 19342481
[TBL] [Abstract][Full Text] [Related]
4. S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability.
Marín N; Zamorano P; Carrasco R; Mujica P; González FG; Quezada C; Meininger CJ; Boric MP; Durán WN; Sánchez FA
Circ Res; 2012 Aug; 111(5):553-63. PubMed ID: 22777005
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo.
Hatakeyama T; Pappas PJ; Hobson RW; Boric MP; Sessa WC; Durán WN
J Physiol; 2006 Jul; 574(Pt 1):275-81. PubMed ID: 16675496
[TBL] [Abstract][Full Text] [Related]
6. Functional significance of differential eNOS translocation.
Sánchez FA; Savalia NB; Durán RG; Lal BK; Boric MP; Durán WN
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1058-64. PubMed ID: 16679407
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction.
Predescu S; Knezevic I; Bardita C; Neamu RF; Brovcovych V; Predescu D
PLoS One; 2013; 8(9):e75846. PubMed ID: 24086643
[TBL] [Abstract][Full Text] [Related]
8.
Zamorano P; Marín N; Córdova F; Aguilar A; Meininger C; Boric MP; Golenhofen N; Contreras JE; Sarmiento J; Durán WN; Sánchez FA
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H66-H71. PubMed ID: 28526707
[TBL] [Abstract][Full Text] [Related]
9. Endothelial mechanisms for inactivation of inflammation-induced hyperpermeability.
Nepali PR; Burboa PC; Lillo MA; Mujica PE; Iwahashi T; Zhang J; Durán RG; Boric M; Golenhofen N; Kim DD; Alves NG; Thomas AP; Breslin JW; Sánchez FA; Durán WN
Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H610-H623. PubMed ID: 36867447
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide, S-nitrosation, and endothelial permeability.
Durán WN; Beuve AV; Sánchez FA
IUBMB Life; 2013 Oct; 65(10):819-26. PubMed ID: 24078390
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
12. Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation.
Wang L; Wu B; Sun Y; Xu T; Zhang X; Zhou M; Jiang W
Br J Anaesth; 2010 May; 104(5):606-12. PubMed ID: 20348139
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase.
Yang Y; Yin J; Baumgartner W; Samapati R; Solymosi EA; Reppien E; Kuebler WM; Uhlig S
Eur Respir J; 2010 Aug; 36(2):417-27. PubMed ID: 19926744
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo.
Durán WN; Seyama A; Yoshimura K; González DR; Jara PI; Figueroa XF; Borić MP
Microvasc Res; 2000 Sep; 60(2):104-11. PubMed ID: 10964584
[TBL] [Abstract][Full Text] [Related]
15. Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules.
Zhou X; He P
Cardiovasc Res; 2010 Jul; 87(2):340-7. PubMed ID: 20080986
[TBL] [Abstract][Full Text] [Related]
16. Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.
Tillery LC; Epperson TA; Eguchi S; Motley ED
Exp Biol Med (Maywood); 2016 Mar; 241(6):569-80. PubMed ID: 26729042
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways.
Igarashi J; Michel T
J Biol Chem; 2001 Sep; 276(39):36281-8. PubMed ID: 11470796
[TBL] [Abstract][Full Text] [Related]
18. Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase.
Erwin PA; Mitchell DA; Sartoretto J; Marletta MA; Michel T
J Biol Chem; 2006 Jan; 281(1):151-7. PubMed ID: 16286475
[TBL] [Abstract][Full Text] [Related]
19. Activation of platelet-activating factor (PAF) receptor stimulates nitric oxide (NO) release via protein kinase C-alpha in HEC-1B human endometrial epithelial cell line.
Dearn S; Rahman M; Lewis A; Ahmed Z; Eggo MC; Ahmed A
Mol Med; 2000 Jan; 6(1):37-49. PubMed ID: 10803407
[TBL] [Abstract][Full Text] [Related]
20. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
